Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae?

被引：30
作者：
Livermore, DM
Brown, DFJ
Quinn, JP
Carmeli, Y
Paterson, DL
Yu, VL
机构：
[1] Cent Publ Hlth Lab, Antibiot Resistance Monitoring & Reference Lab, London NW9 5HT, England
[2] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Cambridge, England
[3] Cook Cty Hosp, Dept Med, Chicago, IL 60612 USA
[4] Rush Univ, Chicago, IL 60612 USA
[5] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[6] Univ Pittsburgh, Med Ctr, Div Infect Dis, Pittsburgh, PA 15213 USA
[7] VA Med Ctr, Infect Dis Sect, Pittsburgh, PA 15240 USA
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2004年 / 10卷 / 01期
关键词：
D O I：
10.1111/j.1469-0691.2004.00831.x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：84 / 85
页数：2
相关论文
共 15 条
[1]   Imipenem resistance of Enterobacter aerogenes mediated by outer membrane permeability [J].
Bornet, C ;
Davin-Regli, A ;
Bosi, C ;
Pages, JM ;
Bollet, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (03) :1048-1052
[2]   Emergence of antibiotic-resistant Pseudomonas aeruginosa:: Comparison of risks associated with different antipseudomonal agents [J].
Carmeli, Y ;
Troillet, N ;
Eliopoulos, GM ;
Samore, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1379-1382
[3]   ENTEROBACTER BACTEREMIA - CLINICAL-FEATURES AND EMERGENCE OF ANTIBIOTIC-RESISTANCE DURING THERAPY [J].
CHOW, JW ;
FINE, MJ ;
SHLAES, DM ;
QUINN, JP ;
HOOPER, DC ;
JOHNSON, MP ;
RAMPHAL, R ;
WAGENER, MM ;
MIYASHIRO, DK ;
YU, VL .
ANNALS OF INTERNAL MEDICINE, 1991, 115 (08) :585-590
[4]   Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species [J].
Cosgrove, SE ;
Kaye, KS ;
Eliopoulous, GM ;
Carmeli, Y .
ARCHIVES OF INTERNAL MEDICINE, 2002, 162 (02) :185-190
[5]  
FISH DN, 1995, PHARMACOTHERAPY, V15, P279
[6]   Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins [J].
FungTomc, JC ;
Gradelski, E ;
Huczko, E ;
Dougherty, TJ ;
Kessler, RE ;
Bonner, DP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (05) :1289-1293
[7]   Cephalosporinase induction and cephalosporin resistance: a longstanding misinterpretation [J].
Goldstein, FW .
CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (12) :823-825
[8]   THE RELATIONSHIP BETWEEN ANTECEDENT ANTIBIOTIC USE AND RESISTANCE TO EXTENDED-SPECTRUM CEPHALOSPORINS IN GROUP-I BETA-LACTAMASE-PRODUCING ORGANISMS [J].
JACOBSON, KL ;
COHEN, SH ;
INCIARDI, JF ;
KING, JH ;
LIPPERT, WE ;
IGLESIAS, T ;
VANCOUWENBERGHE, CJ .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (05) :1107-1113
[9]   Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. [J].
Kaye, KS ;
Cosgrove, S ;
Harris, A ;
Eliopoulos, GM ;
Carmeli, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) :2628-2630
[10]   Seizures in the critically ill: The role of imipenem [J].
Koppel, BS ;
Hauser, WA ;
Politis, C ;
van Duin, D ;
Daras, M .
EPILEPSIA, 2001, 42 (12) :1590-1593
12